title: Synthesis and in vitro evaluation of 5-fluoro-6-[(2-iminopyrrolidin-1-YL)methyl]uracil, TPI(F): an inhibitor of human thymidine phosphorylase (TP).
abstract: An investigation was conducted to determine if the 5-fluoro analog of TPI (5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]uracil), a potent inhibitor of human thymidine phosphorylase (TP), has an IC(50) in a range that might allow to use it labeled for imaging of TP expression in vivo. The previously unreported fluoro analog, TPI(F), was prepared and tested against TPI and TPI(Br) using an inhibition assay of [H-3]thymidine cleavage. An assay, performed in the presence of 0.4 mg/ml of human TP, yielded IC(50) values of 2.5 nM, 2.7 nM, and 9.0 nM for TPI, TPI(Br), and TPI(F), respectively. The results indicate that further studies to develop (18)F-labeled TPI(F) as a potential radiopharmaceutical for PET imaging of TP expression in vivo are warranted.
authors.affiliation: Department of Radiology, Division of Nuclear Medicine, University of Washington, Seattle, Washington, USA.
authors.forename: John R
authors.initials: JR
authors.lastname: Grierson
authors.forename: J Scott
authors.initials: JS
authors.lastname: Brockenbrough
authors.forename: Janet S
authors.initials: JS
authors.lastname: Rasey
authors.forename: Linda
authors.initials: L
authors.lastname: Wiens
authors.forename: Hubert
authors.initials: H
authors.lastname: Vesselle
mesh_terms: D002384:Catalysis / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D020128:Inhibitory Concentration 50; D011759:Pyrrolidines / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D013936:Thymidine / Q000737:chemistry / Q000378:metabolism; D013939:Thymidine Phosphorylase / Q000037:antagonists & inhibitors*; D014498:Uracil / Q000031:analogs & derivatives* / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*
chemical_list: C552315:5-fluoro-6-((2-iminopyrrolidin-1-yl)methyl)uracil; D004791:Enzyme Inhibitors; D011759:Pyrrolidines; D014498:Uracil; D013939:Thymidine Phosphorylase; D013936:Thymidine
references.citation: Bioorg Med Chem. 2004 Jul 1;12(13):3443-50
references.pmid: 15186830
references.citation: Bioorg Med Chem Lett. 2006 Oct 1;16(19):5041-6
references.pmid: 16891117
references.citation: Oncogene. 2002 Dec 5;21(55):8477-85
references.pmid: 12466967
references.citation: Nucl Med Biol. 2007 Jul;34(5):471-8
references.pmid: 17591546
references.citation: Circ Res. 2009 Jan 2;104(1):32-40
references.pmid: 19023133
references.citation: Biochem Pharmacol. 2000 May 15;59(10):1227-36
references.pmid: 10736423
references.citation: Blood. 1969 May;33(5):759-71
references.pmid: 4305274
references.citation: Org Biomol Chem. 2009 Apr 7;7(7):1337-48
references.pmid: 19300818
references.citation: J Med Chem. 1996 Feb 2;39(3):669-72
references.pmid: 8576908
references.citation: Lancet Oncol. 2005 Mar;6(3):158-66
references.pmid: 15737832
references.citation: Biochem Biophys Res Commun. 2003 Feb 14;301(3):675-9
references.pmid: 12565833
references.citation: Nucleosides Nucleotides Nucleic Acids. 2005;24(5-7):367-73
references.pmid: 16247953
references.citation: Biochem J. 1998 Aug 15;334 ( Pt 1):1-8
references.pmid: 9693094
references.citation: Br J Cancer. 1997;75(4):477-81
references.pmid: 9052396
references.citation: Cancer Res. 2003 Jan 15;63(2):527-33
references.pmid: 12543812